The Efficacy of Adjunctive Therapy with LithoLexal®Respiro in Adult Patients with Moderate-to-Severe COPD: A Real-World Objective and Subjective Study
DOI:
https://doi.org/10.17140/prrmoj-6-141Keywords:
Chronic Obstructive Pulmonary Disease, Respiratory Function Test, Anti Inflammatory Agents, Magnesium, LithoLexal RespiroAbstract
BackgroundChronic obstructive pulmonary disease (COPD) is a common and progressive respiratory disease associated with significant morbidity and mortality. Although inhaled bronchodilators and corticosteroids are the mainstay of pharmacological treatment, complementary adjunctive therapies are being explored to improve patient outcomes. LithoLexal® Respiro (Nordic Medical Ltd., London, UK) is a marine-derived plant extract containing >70 macro and trace biominerals, enriched with a bioavailable seawater-derived magnesium and vitamin D. Given its documented in-vitro and in-vivo anti-inflammatory activities, this treatment is a potential candidate for adjunctive therapy of COPD. Current study aimed to evaluate the efficacy of LithoLexal® Respiro in improving lung function and overall health in COPD patients.
Methods
This single-arm, real-world study evaluated the efficacy of adjunctive therapy with LithoLexal® Respiro in adult patients with moderate-to-severe COPD. Participants were recruited from the United Kingdom and received one tablet of LithoLexal® Respiro twice daily for four months. Objective and subjective outcome measures were used to assess clinical outcomes.
Results
Fourty-nine (49) participants completed the study. There was a significant difference in mean peak expiratory flow rate (PEFR) across the time course of the study. PEFR increased by 36.1 L/min (range: 32.4-39.7 L/min) after four months compared to the baseline (p<0.001). A significant improvement in self-evaluated overall health (1.9 units increase in mean score, p<0.001) was also observed at study end. LithoLexal® Respiro was well tolerated with an adherence rate of 90%.
Conclusion
This study suggests that by improving lung function and perceived health, LithoLexal® Respiro may be a safe and effective adjunctive therapy combined with pharmacotherapy regimens in adult patients with COPD. Further randomized controlled trials are warranted to confirm these findings and determine the optimal dosing regimen.
References
World Health Organization (WHO). Chronic obstructive pulmo-nary disease (COPD). Websit. https://www.who.int/news-room/ fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed March 31, 2023.
Wacker ME, Jörres RA, Karch A, et al. Direct and indirect costs of COPD and its comorbidities: Results from the German COSY-CONET study. Respir Res. 2019; 20(1): 117.
Global Initiative for Chronic Obstructive Lung Disease. Glob-al strategy for the diagnosis, management, and prevention of COPD. 2022 report. Website. https://goldcopd.org/wp-content/ uploads/2021/11/GOLD-2022-REPORT-ver1.1-1.pdf. Accessed March 31, 2023.
Berthon BS, Wood LG. Nutrition and respiratory health--feature review. Nutrients. 2015; 7(3): 1618-1643. doi: 10.3390/nu7031618
King DA, Cordova F, Scharf SM. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5(4): 519- 523. doi: 10.1513/pats.200707-092ET
Aslam MN, Kreider JM, Paruchuri T, et al. A mineral-rich extract from the red marine algae Lithothamnion calcareum preserves bone structure and function in female mice on a Western-style diet. Calcif Tissue Int. 2010; 86(4): 313-324. doi: 10.1007/s00223- Original Research | Volume 6 | Issue 1 | 010-9340-9
O’Gorman DM, Naderi Z, Yeganeh A, Malboosbaf R, Eriksen EF. Disease-Modifying Adjunctive Therapy of Osteopenia and Osteoporosis with a Multimineral Marine Extract, LithoLexal® Bone. Osteology. 2023; 3(1): 22-32. doi: 10.3390/osteology3010004
O’Gorman DM, O’Carroll C, Carmody RJ. Evidence that ma-rine-derived, multimineral, Aquamin inhibits the NF-kappaB sig-naling pathway in vitro. Phytother Res. 2012; 26(4): 630-632. doi: 10.1002/ptr.3601
Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59(7): 574- 580. doi: 10.1136/thx.2003.019588
Spivey WH, Skobeloff EM, Levin RM. Effect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med. 1990; 19(10): 1107-1112. doi: 10.1016/s0196-0644(05)81513-6
Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D to pre-vent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019; 74(4): 337-345. doi: 10.1136/thoraxjnl-2018-212092
Yamshchikov AV, Desai NS, Blumberg HM, et al. Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocr Pract. 2009; 15(5): 438-449. doi: 10.4158/EP09101.ORR
Jackson H, Hubbard R. Detecting chronic obstructive pul-monary disease using peak flow rate: cross sectional survey. BMJ. 2003; 327(7416): 653-654. doi: 10.1136/bmj.327.7416.653
Duong M, Usman A, Ma J, et al. Associations between lung function and physical and cognitive health in the Canadian Lon-Submit your article to this journal | https://openventio.org/online-manuscript-submission-system/ Original Research | Volume 6 | Issue 1 | Eriksen EF, et al gitudinal Study on Aging (CLSA): A cross-sectional study from a multicenter national cohort. PLoS Med. 2022; 19(2): e1003909. doi: 10.1371/journal.pmed.1003909
Ryan S, O’Gorman DM, Nolan YM. Evidence that the ma-rine-derived multi-mineral Aquamin has anti-inflammatory effects on cortical glial-enriched cultures. Phytother Res. 2011; 25(5): 765- 767. doi: 10.1002/ptr.3309
Aslam MN, Paruchuri T, Bhagavathula N, et al. A mineral-rich red algae extract inhibits polyp formation and inflammation in the gastrointestinal tract of mice on a high-fat diet. Integr Cancer Ther. 2010B; 9(1): 93-99 doi: 10.1177/1534735409360360
Hampton AL, Aslam MN, Naik MK, et al. Ulcerative derma-titis in C57BL/6NCrl mice on a low-fat or high-fat diet with or without a mineralized red-algae supplement. J Am Assoc Lab Anim Sci. 2015; 54(5): 487-496.
Murphy CT, Martin C, Doolan AM, et al. The marine-derived, multi-mineral formula, aquaPT reduces TNF-α levels in osteoar-thritis patients. J Nut Health Food Sci. 2014; 2: 1-3. doi: 10.15226/ jnhfs.2014.00124
Spivey WH, Skobeloff EM, Levin RM. Effect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med. 1990; 19(10): 1107-1112. doi: 10.1016/s0196-0644(05)81513-6
Aziz HS, Blamoun AI, Shubair MK, et al. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: A retrospective study. Ann Clin Lab Sci. 2005; 35(4): 423- 427.
Banerjee A, Panettieri R Jr. Vitamin D modulates airway smooth muscle function in COPD. Curr Opin Pharmacol. 2012; 12(3): 266- 274. doi: 10.1016/j.coph.2012.01.014
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Pulmonary Research and Respiratory Medicine (PRRM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
